Published: 13 February 2020
Author(s): Giacomo Buso, Adriano Alatri, Luca Calanca, Marco Fresa, Salah-Dine Qanadli, Raffaele Pesavento, Lucia Mazzolai
Section: Original article

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a serious and potentially fatal disease, with an estimated annual incidence of 104–183 per 100,000 person-years in the general population [1]. Standard treatment for acute VTE is based on anticoagulation (AC). Nonetheless, when AC therapy is contraindicated, use of an inferior vena cava filter (IVCF) may be considered [2]. Several types of IVCF have been developed over time, including permanent and optional devices.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.